Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of Vater

Digestive Surgery

Volumn 16, Issue 2, 1999, Pages 145-151

  Mantke, R ^a   Manger, Th ^a   Schulz, H U ^a   Ridwelski, K ^a   Pross, M ^a   Gunther Th ^a   Lippert, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ampulla of Vater; Carcinoid; Medical treatment; Neuroendocrine tumors; Pancreas; Surgical treatment

Indexed keywords

ALPHA INTERFERON; OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; APPENDIX; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HORMONE SYNTHESIS; HUMAN; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PANCREATICODUODENECTOMY; SMALL INTESTINE; SUBCUTANEOUS DRUG ADMINISTRATION; VATER PAPILLA;

EID: 0032942021     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018708     Document Type: Article

References (37)

1. Välimäki M, Järvinen HJ, Salmela P, Sane T, Sjöblom SM, Pelkonen R: Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer 1991;67: 547-549.
2. De Vries EGE, Kema IP, Sloof MJH, Verschueren RCJ, Kleibeuker JH, Mulder NH, Sleijfer CTh, Willemse PHB: Recent developments in diagnosis and treatment of metastatic carcinoid tumors. Scand J Gastroenterol 1993; 28:87-93.
3. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G: Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995;425:547-560.
4. Thompson GB, Heerden JA, Martin JK, Schutt AJ, Ilstrup DM, Carney JA: Carcinoid tumors of the gastrointestinal tract: Presentation, management and prognosis. Surgery 1985;98: 1054-1063.
5. Maurer CA, Baer H-U, Dyong TH, Mueller-Garamvoelgyi E, Friess H, Ruchti C, Reubi J-C, Büchler MW: Carcinoid of the pancreas: Clinical characteristics and morphological features. Eur J Cancer 1996;32A:1109-1116.
6. Martin JK, Moertel CG, Adson MA, Schutt AJ: Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 1983;118:537-542.
7. Lamberts SWJ, Krenning EP, Klijn JM, Reubi JC: The clinical use of somatostatin analogues in the treatment of cancer. Baillières Clin Endocrinol Metab 1990;4:29-49.
8. Rappel S, Altendorf-Hofmann A, Stolte M: Prognosis of gastric carcinoid tumors. Digestion 1995;56:455-462.
9. Buchanan KD, Johnston CF, O'Hare MMT, Ardill JES, Shaw C, Collins JSA, Watson RGP, Atkinson AB, Hadden DR, Kennedy TL: Neuroendocrine tumors - A European view. Am J Med 1986;81:14-22.
10. Modlin IM, Sandor AS: An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79: 813-829.
11. Pelley RJ, Bukowski RM: Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 1997;9:68-74.
12. Neary PC, Redmond PH, Houghton T, Watson GRK, Bouchier-Hayes D: Carcinoid disease. Review of the literature. Dis Colon Rectum 1997;40:349-362.
13. Godwin JD: Carcinoid tumors: An analysis of 2837 cases. Cancer 1975;36:560-569.
14. Mitty HA, Warner RRP, Newman LH, Train JS, Parnes ICH: Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985;155:623-626.
15. Zietels J, Naunheim K, Kaplan EL, Strauss F: Carcinoid tumors: 37 year's experience. Arch Surg 1982;117:732-736.
16. Meyer-Pannwitt U, Kummerfeld K, Froeschle G, Dorss VA, Klapdor R: Is neuron-specific enolase a useful tumor marker in the diagnosis and follow-up of patients with abdominal neuroendocrine tumors? Endocr Relat Cancer 1995;2:311-319.
17. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG: Treatment of the malignant carcinoid syndrome. N Engl J Med 1986;315:663-666.
18. Saltz L, Trochanowski B, Buchley M, Heffermann B, Niedzwiecki D: Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer 1993;72:244-248.
19. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ: Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993;20:283-292.
20. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP: Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-1249.
21. Memon MA, Nelson HN: Gastrointestinal carcinoid tumors. Current management strategies. Dis Colon Rectum 1997;40:1101-1118.
22. Phan GQ, Yeo CJ, Cameron JL, Maher MM, Hruban RH, Udelsmann R: Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: Fifty patients. Surgery 1997; 122:989-997.
23. Höfler H, Stier A, Schusdziarra V, Siewert JR: Klassifikation der neuroendocrinen Tumoren des Gastrointestinaltrakts und des Pancreas und ihre therapeutische Relevanz. Chirurg 1997;68:107-115.
24. Takada T, Yasuda H, Amano H, Yoshida M, Uchida T: Simultaneous hepatic resection with pancreato-duodenoectomy for metastatic pancreatic head carcinoma: Does it improve survival? Hepatogastroenterology 1997;44:567-573.
25. Lehnert T, Knaebel HP: Diagnostik und Therapie von Lebermetastasen neuroendocriner Tumoren. Chirurg 1997;68:122-131.
26. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK: Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169:36-42.
27. Lee YTN: Liver function tests after ligation of hepatic artery. J Surg Oncol 1978;10:305-320.
28. Perry LJ, Stuart K, Stokes KR, Clouse ME: Hepatic arterial embolization for metastatic neuroendocrine tumors. Surgery 1994;116: 1111-1116.
29. Faiss S, Scherlubl H, Riecken EO, Wiedenmann B: Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 1996;142: 193-207.
30. Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjo J, Dolva LO: Treatment of malignant metastatic midgut carcinoid tumors with recombinant human alpha2b interferon with or without prior hepatic artery embolization. Scand J Gastroenterol 1989;24:787-795.
31. Ahlman H, Westberg G, Waengberg B, Nilsson O: Treatment of liver metastases of carcinoid tumors. World J Surg 1996;20:196-202.
32. Arnold R, Frank M, Kajdan U: Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 1994;55:107-113.
33. Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GFW, Hemming P, Ringe B, Pichlmayr R: Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997; 225:347-353.
34. Oeberg K: Endocrine tumors of the gastrointestinal tract: Systemic treatment. Anticancer Drugs 1994;5:503-519.
35. Wiedemann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G, Öberg K: Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: General recommendations by a consensus workshop. World J Surg 1998;22:309-318.
36. Moertel CG, Hanley JA: Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials 1979;2:327-334.
37. Haller DG, Schutt A, Dayal Y: Chemotherapy for metastatic carcinoid tumors. Proc ASCO 1990;9:102.